| Autor: |
Wang M; Qingdao Municipal Hospital, Qingdao, China., Qi J; Qingdao Municipal Hospital, Qingdao, China., Liu Y; Qingdao Women and Children's Hospital, Qingdao, China. |
| Jazyk: |
angličtina |
| Zdroj: |
Drug discoveries & therapeutics [Drug Discov Ther] 2023 Jul 12; Vol. 17 (3), pp. 177-182. Date of Electronic Publication: 2023 Jun 16. |
| DOI: |
10.5582/ddt.2023.01022 |
| Abstrakt: |
The coronavirus disease 2019 (COVID-19) vaccines have been shown to be effective in protecting people from severe disease progression, hospitalisation and death. However, a wide range of side effects have been reported worldwide. New onset or flare-up of autoimmune hepatitis (AIH) is an extremely rare adverse event following COVID-19 vaccination, with the majority of cases presenting with mild symptoms. Unfortunately, there have been cases of fatal complications. In this mini-review, we have summarised the clinical characteristics of a total of 35 currently reported cases of AIH after COVID-19 vaccination and suggest that patients with autoimmune diseases may be at higher risk of developing AIH after vaccination. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
